Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-16

Clinical Trial Update: Prevention of Acute Mountain Sickness by Intermittent Hypoxia [NA]

View source ↗

Summary

The study, sponsored by Heidelberg University, evaluates whether intermittent hypoxia can prevent Acute Mountain Sickness. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Heidelberg University | Conditions: Acute Mountain Sickness | NA | Status: COMPLETED